Quantedge Capital’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.5M Buy
408,111
+16,900
+4% +$361K 5.69% 3
2026
Q1
$7.91M Sell
391,211
-377,200
-49% -$8.39M 4.32% 5
2025
Q4
$14.7M Sell
768,411
-291,700
-28% -$6.14M 7.02% 4
2025
Q3
$25.5M Buy
1,060,111
+1,036,111
+4,317% +$24.2M 13.97% 2
2025
Q2
$467K Buy
+24,000
New +$355K 0.43% 46

Other funds holding ADNT

Quantedge Capital's ADNT Position: Q2 2026 in Review

Quantedge Capital increased its Adient (ADNT) stake by 4.3% in Q2 2026, buying an estimated $361K and bringing the position to 408,111 shares worth $7.5M. The position accounts for 5.69% of the portfolio, ranked #3.

Quantedge Capital first reported a position in ADNT in Q2 2025 and has held it in 5 quarters since. The position peaked at $25.5M in Q3 2025. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Quantedge Capital held 408,111 shares of Adient worth $7.5M as of Q2 2026.
  • Quantedge Capital bought 16,900 Adient shares in Q2 2026, an estimated $361K.
  • Adient made up 5.69% of Quantedge Capital's portfolio in Q2 2026, its #3 holding.
  • Quantedge Capital first reported a position in Adient in Q2 2025 and has held it in 5 quarters since.
  • Quantedge Capital's Adient position peaked at $25.5M in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Quantedge Capital's 13F filing for Q2 2026, filed 6 Aug 2026.